There have been many studies conducted on the effects that CBD may have to fight the current pandemic sweeping the nation, COVID-19. Many studies have found similar results- CBD has been found to reduce lung damage induced by cytokine storms caused by COVID-19 through enabling an increase in levels of a natural peptide by the name of apelin. Researchers from the Dental College of Georgia (DCG) and the Medical College of Georgia (MCG) found that CBD has the ability to increase oxygen levels and reduce inflammation and physical lung damage related to adult respiratory distress syndrome (ARDS). You can see the results of that study in the Journal of Cellular and Molecular Medicine.

CBD Helps Reduce Inflammation

Apelin plays an important role in bringing both blood pressure and inflammation down, but researchers from DCG and MCG found that levels of apelin would drop to near zero if someone is infected with COVID-19. Once CBD was administered into the bloodstream, apelin would increase by at least 20 times. When blood pressure gets to high levels, apelin levels should be parallel to help reduce the pressure. Apelin should help do the same to normalize inflammation in the lungs and related breathing issues associated with ARDS, but this was not the case. Apelin seemed to only increase once CBD was administered.

More Studies Must Be Done

Although studies are still being conducted, researchers from the DCG and the MCG have surprisingly found that CBD helps significantly increase apelin levels when faced with COVID-19. Treatment with CBD normalized the immune response and apelin levels, along with oxygen levels, swelling, and scarring in the lungs. Researchers add that CBD appears to be a natural apelin agonist.

Protect Yourself with Asterra Labs Quality CBD

Asterra Labs offers immediate-release and extended-release CBD tablets in three different strengths (25mg, 50mg, & 100mg) to give our customers the greatest flexibility and autonomy in dosing according to their individual needs. Click here to learn more and try some today!

Back to blog